Procurement Summary
Country: Brazil
Summary: Medicines with Brands Determined to Comply with Court Orders.
Deadline: 11 May 2026
Posting Date: 10 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139335146
Document Ref. No.: 90052/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Medicines with brands determined to comply with court orders. UASG code: 90139 Notice from: 04/10/2026 from 08:00 to 12:00 and from 13:00 to 16:59 Proposal Delivery: from 04/10/2026 at 08:00 MELATONIN, 5 MG CONCENTRATION, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED Quantity: 120 LEVETIRACETAM, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION Quantity: 2100 OXICODONE HYCLORHYDRATE, COMPOSITION ASSOCIATED WITH NALOXONE, CONCENTRATION 20 MG + 10 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE Quantity: 252 OXICODONE HYCLORHYDRATE, COMPOSITION ASSOCIATED WITH NALOXONE HYCLORIDATE, CONCENTRATION 10 MG + 5 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE Quantity: 252 ATOMOXETINE, CONCENTRATION 10 MG Quantity: 120 EVOGLYPTIN, CONCENTRATION 5 MG Quantity: 120 SALBUTAMOL, CONCENTRATION 1 MG/ML, PHARMACEUTICAL FORM NEBULIZATION SOLUTION Quantity: 240 LEVOCETIRIZINE, DIPROPIONATE SALT COMPOSITION, CONCENTRATION 5 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION Quantity: 40 FORMOTEROL FUMARATE, COMPOSITION ASSOCIATED WITH BUDESONIDE, CONCENTRATION 6 MCG +200 MCG/DOSE, PHARMACEUTICAL FORM AEROSOL SUSPENSION FOR INHALATION, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE Quantity: 12 MEDICINAL EXTRACT, ACTIVE INGREDIENT HORSE CHESTNUT (AESCULUS HIPPOCASTANUM L.), CONCENTRATION 263.2 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE Quantity: 240 ZIPRASIDONE, COMPOSITION HYCLORYDRATE SALT, CONCENTRATION 80 MG Quantity: 240
Documents
Tender Notice